Claudia L. Melo-Sossa

Bucaramanga, SAN, Colombia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

Journal: American journal of hematology

Published: February 05, 2026

Health-Related Quality of Life Among Female Carriers of Haemophilia and Non-Carriers in a Colombian Population.

Health-Related Quality of Life Among Female Carriers of Haemophilia and Non-Carriers in a Colombian Population.

Journal: Haemophilia : the official journal of the World Federation of Hemophilia

Published: November 11, 2025

A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.

A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.

Journal: Haematologica

Published: June 26, 2025

Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry.

Long-term benefits of autologous stem cell transplantation versus intensive chemotherapy consolidation for acute myeloid leukemia patients: A propensity score matching analysis from the PETHEMA AML registry.

Journal: Leukemia

Published: April 21, 2025

Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study.

Characteristics, outcomes and treatment patterns in acute myeloid leukemia patients 60 years or older in Colombia: a RENEHOC-PETHEMA study.

Journal: Annals of hematology

Published: September 19, 2024

Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.

Health care systems as determinants of outcomes in multiple myeloma: final results from the Latin American MYLACRE study.

Journal: Blood advances

Published: June 26, 2024

Decitabine versus intensive chemotherapy induction for older patients with acute myeloid leukaemia: a futile but successful trial.

Decitabine versus intensive chemotherapy induction for older patients with acute myeloid leukaemia: a futile but successful trial.

Journal: The Lancet. Haematology

Published: October 09, 2023

Priapism as the first manifestation in chronic myeloid leukemia: A case report and focused review of literature.

Priapism as the first manifestation in chronic myeloid leukemia: A case report and focused review of literature.

Journal: Clinical case reports

Published: March 20, 2021

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

Journal: Transplantation and cellular therapy

Published: November 07, 2020

Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].

Corrigendum to "Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study" [Leuk. Res. 92 (March) (2020) 106352].

Journal: Leukemia research

Published: July 19, 2020

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.

Journal: Leukemia research

Published: November 06, 2019

Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report.

Autologous hematopoietic stem cell transplantation in a patient with refractory seropositive myasthenia gravis: A case report.

Journal: Neuromuscular disorders : NMD

Published: June 18, 2018

Showing 1-12 of 13

Last Updated: 09/26/2026